Annual EBITDA
-$104.64 M
-$13.35 M-14.63%
December 31, 2023
Summary
- As of February 8, 2025, PHVS annual EBITDA is -$104.64 million, with the most recent change of -$13.35 million (-14.63%) on December 31, 2023.
- During the last 3 years, PHVS annual EBITDA has fallen by -$74.98 million (-252.83%).
- PHVS annual EBITDA is now -1954.24% below its all-time high of -$5.09 million, reached on December 31, 2018.
Performance
PHVS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$41.64 M
-$4.69 M-12.70%
September 1, 2024
Summary
- As of February 8, 2025, PHVS quarterly EBITDA is -$41.64 million, with the most recent change of -$4.69 million (-12.70%) on September 1, 2024.
- Over the past year, PHVS quarterly EBITDA has dropped by -$10.96 million (-35.71%).
- PHVS quarterly EBITDA is now -1062.80% below its all-time high of -$3.58 million, reached on March 1, 2020.
Performance
PHVS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$138.46 M
-$13.18 M-10.52%
September 1, 2024
Summary
- As of February 8, 2025, PHVS TTM EBITDA is -$138.46 million, with the most recent change of -$13.18 million (-10.52%) on September 1, 2024.
- Over the past year, PHVS TTM EBITDA has dropped by -$25.71 million (-22.80%).
- PHVS TTM EBITDA is now -3529.77% below its all-time high of -$3.81 million, reached on December 1, 2019.
Performance
PHVS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PHVS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.6% | -35.7% | -22.8% |
| 3 y3 years | -252.8% | -35.7% | -22.8% |
| 5 y5 years | -1954.2% | -35.7% | -22.8% |
PHVS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -63.6% | at low | -298.4% | +18.6% | -108.6% | at low |
| 5 y | 5-year | -1067.0% | at low | -1062.8% | +18.6% | -3529.8% | at low |
| alltime | all time | -1954.2% | at low | -1062.8% | +18.6% | -3529.8% | at low |
Pharvaris NV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$41.64 M(+12.7%) | -$138.46 M(+10.5%) |
| Jun 2024 | - | -$36.95 M(+20.4%) | -$125.28 M(+11.1%) |
| Mar 2024 | - | -$30.68 M(+5.1%) | -$112.75 M(+7.8%) |
| Dec 2023 | -$104.64 M(+14.6%) | -$29.20 M(+2.6%) | -$104.64 M(-17.3%) |
| Sep 2023 | - | -$28.45 M(+16.5%) | -$126.58 M(+16.1%) |
| Jun 2023 | - | -$24.42 M(+8.2%) | -$109.04 M(+14.7%) |
| Mar 2023 | - | -$22.57 M(-55.9%) | -$95.07 M(+5.2%) |
| Dec 2022 | -$91.29 M(+42.7%) | -$51.14 M(+368.9%) | -$90.35 M(+35.5%) |
| Sep 2022 | - | -$10.91 M(+4.4%) | -$66.69 M(+0.5%) |
| Jun 2022 | - | -$10.45 M(-41.5%) | -$66.37 M(-10.5%) |
| Mar 2022 | - | -$17.85 M(-35.0%) | -$74.14 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$63.96 M(+115.7%) | -$27.48 M(+159.6%) | -$70.55 M(+26.3%) |
| Sep 2021 | - | -$10.58 M(-41.9%) | -$55.86 M(+6.2%) |
| Jun 2021 | - | -$18.22 M(+27.7%) | -$52.61 M(+29.3%) |
| Mar 2021 | - | -$14.27 M(+11.5%) | -$40.70 M(+35.6%) |
| Dec 2020 | -$29.66 M(+230.7%) | -$12.79 M(+74.4%) | -$30.01 M(+42.7%) |
| Sep 2020 | - | -$7.33 M(+16.3%) | -$21.03 M(+53.5%) |
| Jun 2020 | - | -$6.30 M(+76.1%) | -$13.70 M(+85.2%) |
| Mar 2020 | - | -$3.58 M(-6.1%) | -$7.40 M(+93.9%) |
| Dec 2019 | -$8.97 M(+76.0%) | - | - |
| Dec 2019 | - | -$3.81 M | -$3.81 M |
| Dec 2018 | -$5.09 M | - | - |
FAQ
- What is Pharvaris NV annual EBITDA?
- What is the all time high annual EBITDA for Pharvaris NV?
- What is Pharvaris NV annual EBITDA year-on-year change?
- What is Pharvaris NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pharvaris NV?
- What is Pharvaris NV quarterly EBITDA year-on-year change?
- What is Pharvaris NV TTM EBITDA?
- What is the all time high TTM EBITDA for Pharvaris NV?
- What is Pharvaris NV TTM EBITDA year-on-year change?
What is Pharvaris NV annual EBITDA?
The current annual EBITDA of PHVS is -$104.64 M
What is the all time high annual EBITDA for Pharvaris NV?
Pharvaris NV all-time high annual EBITDA is -$5.09 M
What is Pharvaris NV annual EBITDA year-on-year change?
Over the past year, PHVS annual EBITDA has changed by -$13.35 M (-14.63%)
What is Pharvaris NV quarterly EBITDA?
The current quarterly EBITDA of PHVS is -$41.64 M
What is the all time high quarterly EBITDA for Pharvaris NV?
Pharvaris NV all-time high quarterly EBITDA is -$3.58 M
What is Pharvaris NV quarterly EBITDA year-on-year change?
Over the past year, PHVS quarterly EBITDA has changed by -$10.96 M (-35.71%)
What is Pharvaris NV TTM EBITDA?
The current TTM EBITDA of PHVS is -$138.46 M
What is the all time high TTM EBITDA for Pharvaris NV?
Pharvaris NV all-time high TTM EBITDA is -$3.81 M
What is Pharvaris NV TTM EBITDA year-on-year change?
Over the past year, PHVS TTM EBITDA has changed by -$25.71 M (-22.80%)